Finance

Lists
Why is TXG up 4,36%?
Dive Deeper
TXG:NASDAQ
10X Genomics Inc
80,65 $
+4,36%
(+3,37) 1D
80,95 $
+0,37% (+0,30)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXG...
Open
78,60 $
High
85,12 $
Low
78,52 $
Mkt. cap
10,51 մլրդ
Avg. vol.
3,43 մլն
Volume
3,68 մլն
52-wk high
102,81 $
52-wk low
11,16 $
EPS
-0,59 $
Beta
1,99
Shares outstanding
120,21 մլն
No. of employees
1 հզր
Open
78,60 $
High
85,12 $
Low
78,52 $
Mkt. cap
10,51 մլրդ
Avg. vol.
3,43 մլն
Volume
3,68 մլն
52-wk high
102,81 $
52-wk low
11,16 $
EPS
-0,59 $
Beta
1,99
Shares outstanding
120,21 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOSerge Saxonov
Employees1,18 հզր
Founded2012
HeadquartersPleasanton, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 16 analysts giving stock ratings to TXG in the past 3 months
Buy
Buy
7
Hold
9
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TXG in the last 3 months.
Highest
Current 80,65 $
110,00 $ (+36,39%)
Average
68,20 $ (-15,44%)
Lowest
40,00 $ (-50,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ryskin
Bank of America Securities
Hold
Maintained
80,00 $
-0,8%
10/09/2026
Luke Sergott
Barclays
Buy
Maintained
110,00 $
+36,4%
10/07/2026
Matt Larew
William Blair
Buy
Maintained
-
-
09/29/2026
Puneet Souda
Leerink Partners
Hold
Maintained
90,00 $
+11,6%
09/29/2026
David Westenberg
Piper Sandler
Hold
Reiterated
80,00 $
-0,8%
09/28/2026
Unknown Analyst
Argus Research
Buy
Initiated
110,00 $
+36,4%
09/28/2026
John Eade
Argus Research
Buy
Initiated
110,00 $
+36,4%
09/25/2026
Unknown Analyst
UBS
Hold
Initiated
68,00 $
-15,7%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
68,00 $
-15,7%
09/09/2026
Dan Leonard
RBC Capital
Hold
Initiated
70,00 $
-13,2%
09/01/2026
Unknown Analyst
Stephens
Buy
Reiterated
65,00 $
-19,4%
08/12/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
50,00 $
-38%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
50,00 $
-38%
08/11/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
60,00 $
-25,6%
08/10/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
40,00 $
-50,4%
08/10/2026
Tycho Peterson
Jefferies
Buy
Reiterated
53,00 $
-34,3%
08/07/2026
Patrick B Donnelly
Citi
Hold
Maintained
50,00 $
-38%
08/07/2026
‏Brendan Digan‏
Citi
Hold
Maintained
50,00 $
-38%
08/07/2026
Daniel Brennan
TD Cowen
Hold
Maintained
47,00 $
-41,7%
07/15/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
23,00 $
-71,5%
05/08/2026
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
0,03 $ / -0,02 $
+258,37%beat
Revenue / Est. (USD)
151,04 մլն / 146,62 մլն
+3,01%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
149,00 մլն
166,03 մլն
150,84 մլն
151,04 մլն
Cost of goods sold
48,70 մլն
52,88 մլն
44,66 մլն
38,54 մլն
Cost of revenue
48,70 մլն
52,88 մլն
44,66 մլն
38,54 մլն
Research and development expenses
57,19 մլն
55,77 մլն
56,85 մլն
56,79 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74,66 մլն
73,02 մլն
66,38 մլն
78,66 մլն
Operating expense
131,85 մլն
128,79 մլն
123,22 մլն
135,45 մլն
Total operating expenses
180,54 մլն
181,67 մլն
167,89 մլն
173,99 մլն
Operating income
-31,54 մլն
-15,64 մլն
-17,05 մլն
-22,96 մլն
Other non operating income
538,00 հզր
-3,04 մլն
-72,00 հզր
-3,49 մլն
EBT including unusual items
-28,20 մլն
-15,19 մլն
-12,85 մլն
-18,64 մլն
EBT excluding unusual items
-26,40 մլն
-12,39 մլն
-12,90 մլն
-22,04 մլն
Income tax expense
-733,00 հզր
1,06 մլն
623,00 հզր
-714,00 հզր
Effective tax rate
2,60%
-6,97%
-4,85%
3,83%
Other operating expenses
-
-
-
-
Net income
-27,47 մլն
-16,25 մլն
-13,47 մլն
-17,93 մլն
Net profit margin
-18,44%
-9,79%
-8,93%
-11,87%
Earnings per share
-0,02
0,07
0,07
0,03
Interest and investment income
5,20 մլն
6,89 մլն
5,01 մլն
4,80 մլն
Interest expense
-
-
-
-
Net interest expenses
5,20 մլն
6,89 մլն
5,01 մլն
4,80 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,24 մլն
-5,58 մլն
-7,09 մլն
-13,29 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps